Track all markets on TradingView Bristol-Myers Squibb (NYSE:BMY), a renowned biopharmaceutical company, recently made headlines with its announcement of a $3 billion stock buyback plan. This decision, seen as a strategic move by the … [Read more...] about Bristol-Myers Squibb’s $3 Billion Stock Buyback: A Strategic Move